TrueScale Capitals leads Series B2 funding for Advamedica
July 27, 2021
Boston, 27th July 2021: Advamedica has raised $6 million in a Series B2 funding round led by TrueScale
Menu
We combine our long biomaterials expertise with the power of proprietary manufacturing platform to develop novel hemostatic, surgical and wound care products. Current area of focus is in improving patient outcomes in pre-hospital, intra-operative, and post-operative clinical settings.
*Axiostat uses Protonated Bioadhesive Technology developed by Advamedica which is approved in 40+ countries. Axiostat Patch: FDA 510k K202830, Axiostat Chitosan Haemostatic Dressing: FDA 510k K172324. For more info, visit axiostatusa.com
Boston, 27th July 2021: Advamedica has raised $6 million in a Series B2 funding round led by TrueScale
A biomaterial-focused MedTech startup has announced FDA 510(k) clearance of its hemostatic product…
Advamedica has been selected for MedTech Innovator US Military Pitch (May 2020) to pitch its Military…
President
SVP, North America & International
National Sales Director
Director - Clinical Marketing
Director, Quality & Regulatory (Int.)
Chief Financial Officer (Int.)
Associate Professor of Medicine Harvard Medical School
Professor of Emergency Medicine Stanford University Medical Centre
Advamedica Inc.
Harvard Square,
1 Mifflin Place, Suite 400,
Cambridge, Massachusetts
02138 USA
Dr. Mahadevan is a Professor of Emergency Medicine at Stanford University where he has been a recipient of numerous teaching awards. He also serves as the Director of Global Affairs and Strategy for Stanford Medicine. He received his medical degree from David Geffen School of Medicine at UCLA.
Dr. Sengupta serves as the Associate Professor of Medicine at HMS and as the Associate Professor of Health Sciences and Technology at MIT. Dr. Sengupta received his PhD from University of Cambridge as a British Chevening and Nehru Scholar, and is a recipient of the TR35 Innovator Award from the MIT Technology Review Magazine and the Era of Hope Scholar Award from the US Department of Defense.
Satish brings a wealth of diverse experiences to his CFO role at Advamedica. In addition to his Fortune 500 roles (FedEx, Citi, AmEx, JPM Chase) in various leadership capacities across multiple countries, he has worked with a number of startups and SMBs as their in-house or consulting CFO. Satish has held CFO roles in a number of verticals ranging from education to healthcare and technology companies. In these roles Satish was in charge of all areas of finance including strategy, fundraising, board and investor reporting as well as M&A. Over the last three years Satish has helped companies raise over $100 million in venture capital and financing.
Quality professional with over 25 years of experience in the medical device, pharmaceutical, and software industries.
Maria is specialized in developing and implementing Quality Management Systems and has deep knowledge and experience in audit preparation, resolution/remediation as per regulatory compliance in ISO 13485, 21 CFR Part 820, EU MDR, MDSAP, and other regional regulations (China, Taiwan, Brazil, Japan, Canada, Australia, Korea, Switzerland, etc.)
Samantha is Director of Clinical Marketing at Advamedica. Previously she was Global Training Manager in Terumo Aortic overseeing all training and clinical skills to support their latest endovascular technology. Prior to that Samantha was National Sales & Marketing Manager in Bolton Medical, Italy for almost a decade. She started her career as a OR Nurse before moving to the Medical Devices field. Samantha has done Executive MBA in Strategic marketing and has Degree in Professional nursing from University of Bologna, Italy.
Edward is US – National Sales Director at Advamedica. He comes with many decades of experience selling novel hemostats and woundcare products in over 26 states in the US. He was earlier Regional Sales Director at Z-Medica managing business of their Hemostatic product line to Surgery, Trauma, Critical Care, Cardiology, Emergency Room, Cath Lab / Interventional Radiology, Burn and Wound Care. Prior to that he was responsible for managing Allograft business as Area Business Manager at MTF Biologics. He is passionate about creating top performing teams, driven by diversity, inclusion, values and accountability. Expertise in sales force effectiveness, process initiatives, and personnel management. Edward has a Bachelor of Business Administration from Dowling College.
Leo Mavely is the president of Advamedica Inc. He is passionate about medtech innovations for unmet healthcare needs, and has been featured by Fortune Magazine in 40 under 40 business leaders and by Entrepreneur Magazine in 35 under 35 Game-Changing Entrepreneurs. He holds a Bachelor’s degree in Bioengineering.